Further, microglia with elevated G6PD activity/expression produced excessive NADPH and provided abundant substrate to overactivated NADPH oxidase (NOX2) resulting in exacerbated ROS, which suggests that G6PD and NOX2 are potential therapeutic targets for PD (Tu et al., 2019). The gene discussed is CYBB; the disease is Parkinson disease.